Real-world experience of bimekizumab for adult patients with plaque psoriasis: A 52-week multicenter retrospective study
收藏Mendeley Data2024-06-20 更新2024-06-26 收录
下载链接：
https://data.mendeley.com/datasets/r6jsy48jjn
下载链接
链接失效反馈官方服务：
资源简介：
Our group previously published 16-week real-world evidence supporting the use of bimekizumab, an interleukin (IL)-17A/IL-17F inhibitor, for treatment of plaque psoriasis. However, long-term data remains limited. Herein, we report 1-year real-world evidence results.
创建时间：
2024-06-19
